GGrantIndex
Sort

40,608 grants matching prostate cancer

SPORE IN PROSTATE CANCER

$1,484,662
Johns Hopkins University · P50 · FY2002 · CA

IGF::OT::IGF Topic 352: Cell-Based Models for Prostate Cancer Health Disparity Research - Moonshot Project (Phase II)

$1,484,350
Scott Grindrod · Shuttle Pharmaceuticals, Llc · N01 · FY2018 · CA

SBIR TOPIC 255, PHASE II: SYNTHETIC VACCINES AGAINST PROSTATE CANCER

$1,483,094
Peter Pushko · Medigen, Inc. · N44 · FY2011 · CA

CANCER RESEARCH INFRASTRUCTURE DEVELOPMENT

$1,482,951
Shafiq A Khan · Clark Atlanta University · G12 · FY2015 · MD

Michigan Prostate SPORE

$1,482,465
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2023 · CA

METABOLOMIC PROFILING TO DISTINGUISH RACIALLY DISTINCT PROGNOSTIC MARKERS IN PROSTATE CANCER

$1,481,407
Baylor College Of Medicine · · FY2012 · Department of the Army

The Biology of Prostate Cancer Skeletal Metastases

$1,480,775
Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2023 · CA

The Biology of Prostate Cancer Skeletal Metastases

$1,480,743
Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2021 · CA

MULTIETHNIC/MINORITY COHORT STUDY OF DIET AND CANCER

$1,479,406
University Of Hawaii At Manoa · R01 · FY2000 · CA

Comprehensive Cancer Center of Wake Forest University

$1,479,130
Boris Pasche · Wake Forest University Health Sciences · P30 · FY2014 · CA

Comprehensive Cancer Center of Wake Forest University

$1,479,130
Boris Pasche · Wake Forest University Health Sciences · P30 · FY2015 · CA

SPORE in Prostate Cancer

$1,478,967
Samuel R Denmeade · Johns Hopkins University · P50 · FY2020 · CA

Clark Atlanta University Biomedical Science Development

$1,477,867
Carlton E. Brown · Clark Atlanta University · G12 · FY2011 · RR

COMPARATIVE TRANSCRIPTOMIC AND PROTEOMIC PROFILING OF FULL-LENGTH AR AND AR-V7 SPLICE VARIANT CONDENSATES IN PROSTATE CANCER

$1,477,615
The University Of British Columbia · · FY2025 · Defense Health Agency

PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREEN

$1,477,597
Timothy Church · · N01 · FY2007 · CA

The Pharmacodynamics of Genes and Oligonucleotides

$1,475,639
Rudolph Juliano · Univ Of North Carolina Chapel Hill · P01 · FY2006 · GM

DNA Sequencing and FACS Core Facilities

$1,475,423
Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

Animal Model and Genotyping Core Support Facility

$1,475,369
Wendy Du Bois · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

SENIOR LEADERSHIP

$1,474,987
Joseph Rocco Bertino · Rbhs -Cancer Institute Of New Jersey · P30 · FY2014 · CA

Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center

$1,474,945
Phuoc T. Tran · University Of Maryland Baltimore · U54 · FY2023 · CA

INFLUENCE OF THE UNIQUE TUMOR IMMUNE MICROENVIRONMENT AND THE MICROBIOME ON PROSTATE CANCER IMMUNOTHERAPY RESPONSE IN BLACK MEN

$1,473,751
The Johns Hopkins University · · FY2024 · Defense Health Agency

UTILIZING B7-H3 TARGETED THERAPEUTICS TO PREVENT LETHAL PROSTATE CANCER: THE HELP ELUCIDATE & ATTACK LONGITUDINALLY (HEAL) PROSTATE CANCER TRIAL COHORT

$1,473,751
The Johns Hopkins University · · FY2025 · Defense Health Agency

Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer

$1,473,388
Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2009 · CA

SENIOR LEADERSHIP

$1,472,956
Joseph Rocco Bertino · Rbhs -Cancer Institute Of New Jersey · P30 · FY2015 · CA

SENIOR LEADERSHIP

$1,472,951
Joseph Rocco Bertino · Rbhs -Cancer Institute Of New Jersey · P30 · FY2015 · CA